SINCE THE INITIAL DISCOVERY of ter-in cells of a high proportion of patients minal deoxynucleotidyl transferase (TdT) with ALL (McCaffrey et al., 1973 ; Hutton in cells from a patient with acute lympho- Coleman et al., 1976) . blastic leukaemic (ALL) (McCaffrey et al., High levels of TdT were also found in 1973) the enzyme has been found to be some patients with chronic myelocytic associated with certain types of leukaemia, leukaemia (CML) during blast transformaand makes a clinically relevant biochemical tion (Bhattacharyya, 1975;  McCaffrey marker for the diagnosis and classification Coleman et al., 1976 ; Sarin of these patients. A number of studies et al., 1976) in some patients with acute have indicated that the enzyme is present myelomonocytic leukaemia (AMML) (Colet Present address: Dept. of Internal Medicine, Kyushu University, Fukuoka City, Japan.
* To whom reprint requests should be a(ldressed. man et at., 1974) and in occasional patients with acute myelogeneous leukaemia (AML) (Srivastava et al., 1976) . In addition, a correlation was established with membrane markers typical for some types of leukaemia (Hoffbrand et al., 1977 (Hoffbrand et al., , 1978 . For example, cells from patients in blastic transformation of CML that are characterized by high TdT levels usually display morphologically lymphoid features and carry markers of ALL cells. Furthermore, patients identified by these criteria appear to respond to therapy effective in patients with ALL (Marks et al., 1978) suggesting that the enzyme assay may not only assist in the diagnosis and classification but may also guide the management of some patients.
The enzyme is routinely assayed biochemically in crude cell extracts by measuring the incorporation of deoxynucleotidyl triphosphate in the presence of an oligodeoxynucleotide primer. However, these biochemical determinations require a large number of cells and considerable quantities of radioactive nucleotides. Furthermore, the assay for TdT in crude extracts is difficult, and Baltimore et al. (1976) have indicated that it was necessary to use an ion-exchange chromatographic method for quantitation. This lengthy procedure, together with the requirement for large amounts of cells (108) make their application to routinely obtained tissue specimens difficult, and excludes analysis on hypocellular samples and material from patients in remission. In addition, the biochemical assay is not suitable for correlating the enzyme activity with morphologically defined cell populations. This is feasible with a single-cell immunofluorescence assay for TdT. Such an assay has been described for detection of TdT+ cells in human (Bollum, 1978; Kung et al., 1978) as well as in other species (Gregoire et al., 1977; Sugimoto & Bollum, 1979) . In agreement with previously reported information by Bollum (1978) and Kung et al. (1978) we have established an immunofluorescence assay for TdT and have demonstrated its efficiency and reliability for the determination of TdT in individual cells from leukaemic and non-leukaemic samples.
MATERIALS AND METHODS
Patient material.-l 18 samples of marrow and peripheral blood were obtained from 98 patients with leukaemia and other haematological malignancies. Ten peripheral-blood samples from normal volunteers and 6 specimens of marrow samples from patients without haematological malignancies were used as controls. Patients with leukaemia were diagnosed morphologically as described by Hasselback et al. (1967) . The assessment for TdT by biochemical quantitation or immunofluorescence was performed on mononuclear cells with density less than 1-077 g/ml obtained from buffy-coat preparations by density centrifugation in lymphocyte separation medium (LSM, Litton Bionetics, Kensington, Md., U.S.A.).
Preparation of antiserum.-Terminal transferase was purified from calf thymus as previously reported (Okamura et al., 1978) . The final preparation of the enzyme was homogeneous as assessed by SDS polyacrylamidegel electrophoresis. Two protein bands with mol. wt of 8,000 and 23,000 were identified, that corresponded with the a and fi subunits of the enzyme (Okamura et al., 1978) . 100 ,ug of this purified preparation in Freund's complete adjuvant (Difco, Detroit, U.S.A.) were injected s.c. into New Zealand rabbits. Seven booster injections of 100 ,ug in Freund's incomplete adjuvant were given subsequently at 1-week intervals. The sera were monitored for activity against TdT by microdiffusion analysis and enzyme neutralization tests.
Preparation of F(ab)'2 fragments directed against TdT.-Immunoglobulins (IgG) were prepared from crude antiserum by ammonium sulphate fractionation and purified by DEAE cellulose chromatography as described by Fahey & Terry (1973) . The purified IgG was enriched for anti-TdT activity by affinitycolumn chromatography. Two milligrams of highly purified TdT were covalently linked to 2 g of Sepharose 4B (Pharmacia Fine Chemicals) previously activated by cyanogen bromide. Purified IgG was allowed to bind to the TdT-Sepharose 4B column in the presence of phosphate-buffered saline (PBS) (0-14mM NaCl, 0-02M sodium phosphate, pH 7.2).
After extensive washing with PBS, the IgG bound to the column was eluted with 0-5M NaCl containing 50mM glycine at pH 3 0, as described by Taylor & Schimke (1974) . The IgG preparation was then extensively dialysed against OO1M acetate buffer (pH 4.5) and F(ab)'2 fragments prepared by digestion with hog pepsin (Worthington, New Jersey, U.S.A.) at an enzyme:substrate ratio of 1-5: 100 (w/w) as described (Stanworth & Turner, 1973) . The F(ab)'2 fragments were separated from Fc fragments by passage through Sephacryl S-200 (Pharmacia Fine Chemicals) concentrated to 200 jig/ml using an Amicon filter, and stored at -20°C until used.
Biochemical assay for TdT.-TdT activity was measured biochemically as described previously (Okamura et al., 1978) . Briefly, 108 mononuclear cells from marrow or peripheralblood samples in a volume of 1 ml were sonicated and the extract centrifuged for 60 min at 100,000 g. MnCl2, lmM dithiothreitol and 36 ,ug of heat-activated bovine serum albumin (BSA).
The mixture was incubated at 37°C for 30 min and the trichloroacetic-acid-insoluble counts were measured (Okamura et al., 1978 added for a further incubation period of 30 min at 3700. These slides were washed extensively with large volumes of PBS containing 0-5M NaCl and examined with a fluorescence microscope (Zeiss, Universal) that was also equipped with a phase-contrast attachment. As in the results previously reported by Bollum (1978) and Kung et al. (1978) Fig. 1 Fig. 4 indicates a linear correlation between the percentage of immunofluorescent cells and the proportion generated in the mixture. Furthermore these determinations correlated with the amount of TdT measured biochemically.
Elimination of immunofiuorescence by competition with TdT
To obtain further evidence for specificity we have examined the question whether or not the fluorescence staining of these ALL cells could be eliminated by preincubation of the antiserum with a small quantity of highly purified TdT. Before their use as first antibody in the immunofluorescence assay, 2 Htg of a preparation of F(ab)'2, fragments directed against TdT were incubated with 3 ,ug of highly purified TdT. In control slides 5500 of the ALL cells from the patient stained positive for TdT. No fluorescence was seen after preincubation of the antiserum with highly purified TdT. (Greenwood et al., 1977; Hoffbrand et al., 1977 Hoffbrand et al., , 1978 At present the biological role of TdT in cells from patients with leukaemia is not understood. Although associated with certain types and stages of the disease, the question remains unanswered whether or not the enzyme represents a marker related to certain types of leukaemia or whether TdT activity is expressed by cells of early lymphoid differentiation. It is hoped that a combined approach, using the single-cell immunofluorescence assay on populations of leukaemic cells and normal haemopoietic progenitors selected by growth in specific culture conditions, may lead to further understanding of this phenomenon.
